AI assistant
BIOLIFE SOLUTIONS INC — Director's Dealing 2022
Apr 14, 2022
32106_dirs_2022-04-13_44d1f066-ec20-4b3c-b224-4baadcb6fb55.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2022-04-12
Reporting Person: Foster Karen A. (Chief Quality Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-04-12 | Common Stock | M | 38836 | — | Acquired | 123951 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-04-12 | Restricted Stock Award | $0 | M | 38836 | Disposed | Common Stock (38836) | Direct |
Footnotes
F1: The restricted stock was granted pursuant to BioLife Solutions 2013 Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to 200% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2020 through December 31, 2021 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date).